Government News

  • Acitretin to be included in Schedule H
    4 February 2022

    Acitretin to be included in Schedule H, says Health Ministry

    The Health Ministry says that Acitretin will be included in Schedule H after making an amendment in the Drugs Rules, 1945. Acitretin is an oral retinoid used in the treatment of severe resistant psoriasis.

    Schedule H is a class of prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules, 1945. These are drugs which cannot be purchased over the counter without the prescription of a qualified doctor. The manufacture and sales of all drugs are covered under the Drugs and Cosmetics Act and Rules.

  • 3 February 2022
    PCI proposes M.Pharm pharmacy practice as qualification for clinical pharmacist besides Pharm.D

    Pharmacy Council of India proposed to the principal secretary, Health or technical education of all states and union territories that M.Pharm pharmacy practice to be included as qualification for clinical pharmacist besides Pharm.D.

    The Pharmacy Council of India (PCI) is a statutory body working under the Ministry of Health and Family Welfare. Government of India, New Delhi. It is constituted under the Pharmacy Act, 1948 to regulate the profession and practice of pharmacy in the country.

  • 2 February 2022
    Zydus Cadila starts COVID-19 vaccine supply to Government

    Zydus announced that the company has started the supplies of its COVID-19 vaccine ZyCoV-D, to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad. The group is also planning to make the vaccine available in the private market. ZyCoV-D is a three dose vaccine administered intradermally using the painless PharmaJet® needle free system, Tropis®, on day 0, day 28 and day 56.

  • 2 February 2022
    Budget 2022 disallows Pharma companies to claim tax cut on freebies to doctors

    Budget 2022 disallows pharmaceutical companies to claim tax cut on freebies to doctors under section 37 of the act. It simply means such expenditure can not be claimed as business deduction, and it will be counted as taxable profit of pharmaceutical industries.

  • 1 February 2022
    Technology is kept as center point in Healthcare Budget 2022

    Technology has taken a centre-stage for the Health Sector in the General Budget presented in the Parliament by Smt Nirmala Sitharaman, Union Minister of Finance. Two new digitally underpinned Schemes have been announced which indicate the key role that digital technology is playing in expanding the access of health and medical care across the country.

  • 31 January 2022
    Artificial Intelligence and Digital Medicine are critical to future healthcare

    Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh said here that Artificial Intelligence (AI) and Digital Medicine are critical to future healthcare.

  • 31 January 2022
    Research and Innovation is a necessity for the sustained growth of the pharmaceuticals sector, says Mansukh Mandaviya

    Union Minister for Chemicals and Fertilizers Shri Mansukh Mandaviya launched NIPER Research Portal along with Shri Bhagwanth Khuba, Minister of State for Chemicals and Fertilizers in presence of Dr V. K Paul, Member (Health), Niti Aayog. National Institute of Pharmaceutical Education and Research (NIPER) Research Portal has been created with the aim to disseminate the information about all the NIPERs and their research activities, patents filed and Publication information at one place so that a industry and other stakeholders know about them.

  • 29 January 2022
    NHM, Tata Steel and AIF to Improve Access to Maternal and Neonatal Care in Jharkhand

    An Engagement Coordination and Arrangement (ECA) on Maternal, Adolescent, Child care and Nutrition in Kolhan division in Jharkhand between National Health Mission, Tata Steel Foundation and American India Foundation under the flagship project MANSI+ (Maternal and Neonatal Survival Initiative+) was signed today at the office of National Health Mission (NHM), Ranchi.

  • 27 January 2022
    IPC organised virtual training on Pharmacovigilance for NABH accredited hospitals

     IPC organised the virtual training on Pharmacovigilance for NABH Accredited Hospitals in India on 21st January 2022. The Training Programme was intended to provide a platform for the NABH-Accredited Hospitals to understand the systems and procedures involved in ADR-reporting and relevant practises.

  • 25 January 2022
    CCI approves acquisition of GSK Asia

    The Competition Commission of India (CCI) approves acquisition by GlaxoSmithKline Consumer Healthcare Overseas Limited and GlaxoSmithKline Consumer Healthcare UK Trading Limited (Acquirers) of shareholding in GlaxoSmithKline Asia Private Limited (Target) under Section 31(1) of the Competition Act, 2002.

Subscribe to Government News